Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Opening Keynote Address
Orthopaedic Device Industry Business Models:
2020 and Beyond


Bill Tribe, Ph.D., Partner, A.T. Kearney     
Wednesday, June 15                                                                                                                             

Hot breakfast served at 7:30 a.m., opening remarks at 7:45 a.m.  All invited!

Sponsored by 
Tecomet Logo Black Red 2color

During last year’s closing keynote, Dr. Wael Barsoum underscored the importance of producing transformational, innovative products to stay competitive and maintain a strong company and a healthy supply chain. This year, Dr. Bill Tribe will shine the “innovation lens” on the value of transforming your business.

Dr. Tribe co-authored the often-cited “Medical Devices: Equipped for the Future?” study in which the orthopaedics sector is called out specifically as facing an extreme combination of forces — none of which come as a surprise or are new, but when viewed holistically (as in the image below), paint a rather obvious picture of the need for companies to respond. As you can see, orthopaedics is the only sector with 4 of 5 “hot” areas…and in this case, the odd one out (regulatory scrutiny) is still marked “critical.”

Medical Devices Equipped for the Future Source: A.T. Kearney

From a top-down view, the five “disruptors” listed above are acute (power shift to payors, regulatory scrutiny, unclear sources of innovation, new healthcare delivery models, need to serve lower socio-economic classes). They impact the overall orthopaedic industry intensely – but how are they impacting you? Dr. Tribe’s Keynote Address will take into account the uniqueness of the OMTEC audience: large and small OEMs, Suppliers and Service Providers.  

As stated in the A.T. Kearney study, “Each company faces a different set of headwinds…while the macro-factors held true, individual experiences and prioritization depended on factors such as market geography, product life cycles and go-to-market strategies. The most effective strategies are therefore likely to be company specific.”

What will be your business model in 2020? 2025?
Will you be considering cost-structure, deployment of inventory, commercial logistics, quality and regulatory frameworks, R&D, innovation and data collection?

Dr. Tribe will break down the issues and share potential approaches to help you navigate toward a more relevant and lucrative business model – regardless of where you are in the process.

Read our interview with Dr. Tribe

Reacquaint yourself with just a few of the many industry changes already in progress:
Johnson & Johnson Announces Restructuring Actions in Medical Devices
Three Spine Companies Implement New Manufacturing Strategies
Smith & Nephew’s Syncera Focuses on Organization of OR Instruments
Zimmer Closes Biomet Acquisition


BilL Tribe webBill Tribe is a partner with A.T. Kearney in the Health Practice. In his ten years with the firm, he has worked extensively in Europe and North America, addressing global and regional C-suite issues for many of the leading medical device, pharmaceutical and biologics companies. His expertise spans supply chain strategy, portfolio and product design, product distribution and optimization of service and supply across the extended value chains of suppliers, manufacturers and end-users. Before joining A.T. Kearney, he was involved in start-up companies in Cambridge, pioneering new imaging modalities in areas such as pharmaceutical drug discovery, non-invasive blood monitoring, and cancer screening. Dr. Tribe earned a bachelor’s degree in physics from Imperial College in London and a Ph.D. from Oxford University.